Aaron is responsible for the development of laboratory relationships and agreement on commercial contracts with the labs to enhance the supply of Lab data and increase the Diaceutics Global Lab Network as well as the identification of customers’ market research needs.
Aaron has 12 years sales and marketing experience of reagents and instruments in research and diagnosis markets. Aaron has experience building and managing sales teams as well as developing relationships with KOLs.
Adam facilitates integration of multiple databases to generate simple dashboards providing real-time metrics on all patients and testing, enabling powerful analyses and insights. He has a strong background in assay development, high-throughput screening, complex data analysis, and statistics. He has written many publications and has patented an improvement to a clinical diagnostic tool that has over $10M in annual sales.
As Director of Laboratory Partnership Development, Alan will take a lead in developing and leading Diaceutics’ recruitment of laboratories onto the company’s innovation platform in Europe. He will also interface with the Innovation Team software group to identify stakeholder requirements and feed in high level direction on software being developed.
Alan has over 15 years’ professional experience in business, sales, marketing and commercial operations having worked for Lennox, Leica Biosystems and Beaumont Hospital in Dublin
As Head of PMO Alison will organize and coordinate a portfolio of client projects and internal programs to guide the organization toward project and program efficiencies. She will provide strategic guidance to core teams and project managers and will be responsible for resource planning, timeline and deadline optimization, overall team supervision, interdisciplinary liaison and reporting to EXCO on overall project progress and status.
Alison is an experienced Program Director with more than 15 years professional experience having worked for Qiagen and AstraZeneca.
As a Domain Expert within the Knowledge and Insights Team, Amanda will use her expertise in market access, together with leadership and project management skills to ensure timely execution of high-quality client projects. Amanda has many years experience managing all aspects of market access strategy engagements and has broad subject matter expertise in chronic disease, women’s health, oncology diagnostics (next generation sequencing) and hospital acquired infections.
Amit is responsible for strategic business development and growth. His responsibilities include prospecting and qualifying new business opportunities, client relationship management and alignment with the marketing team. Amit has spent 20 years in developing and commercializing in vitro diagnostics products for cancer, infectious diseases, neurological disorders and agricultural crop protection (GMO). He has academic and professional qualifications in business administration and genetics.
Annie works as a Researcher in Secondary Market Research processing research and data to produce client facing content on diagnostic guidelines and laboratory practices.
Annie started her career in diagnostic laboratories and spent 9 years in Haematology, Molecular and Cytogenetics. Most recently, she has over 5 years of working for UK NEQAS for Leucocyte Immunophenotyping, a haemato-oncological EQA provider.
Antonio executes secondary market research, analyses IVD and local pathology landscapes and builds relationships with KOLs. He has over 13 years experience within Autoimmunity, Molecular Biology and Immunohistochemistry and lab experiences include Immunohistochemistry and FISH; Elisa and IFA methods; Digital microscopy and Flow Cytometry
Bethany works as a Director on the Engagement Team providing tangible insights and solutions to improve precision medicine. Leveraging 8 years of clinical experience in academic and community-based laboratories and an MBA, she works to understand and overcome real-world obstacles in healthcare to enhance our clients’ companion diagnostic commercialization efforts. Her expertise is in understanding diagnostic testing methodologies and assessing strategic business implications.
Bob supports client needs in the development of client deliverables. As a domain expert Bob uses his expertise in personalized medicine, companion diagnostics, healthcare and laboratory practice together with leadership and project management skills to ensure timely execution of high-quality client projects. Bob has over 15 years experience in the biomarker and companion diagnostic industry working for both diagnostic, CRO and Pharma/Biotech companies and has extensive experience in planning and supporting biomarker and companion diagnostic strategies to aid drug development.
As Cloud Architect and Engineer, Brian will work as part of the Diaceutics engineering team to design, document and facilitate the implementation of Diaceutics services and applications via the AWS cloud and ecosystem to support the overall Diaceutics business strategy.
Brian holds a Diploma in Manufacturing Technology, Design and Management as well as a Diploma in Information Engineering and brings many years’ experience in cloud architecture and software engineering having worked for a number of companies such as Nortel Networks, Deloitte and Reward.
Brian is responsible for generating marketing imagery and maintaining the brand guidelines for client deliverables, resources and content developed across the organization. He also works on video production and the company’s digital product platforms. Brian has academic qualifications in computing in games development and several years of professional design experience.
As Principal Software Engineer within the Global Data Team, Brien will be responsible for building scalable and secure data platforms including the design and development of a new Software as a Service (SaaS) platform focused on the digital transformation of how Diaceutics do business with our clients. Brien has many years experience in principal/senior software developer roles and has extensive knowledge of many software tools and processes.
As a Senior Diagnostic Lab Liaison Brigitte will execute primary and secondary market research in Italy, overseeing the execution and facilitation of market research studies along with the development of laboratory relationships and the identification and implementation of customers’ market research. Brigitte will be manging the daily projects and personnel in Italy.
Brigitte has 10 years’ experience in both academic and commercial roles with her most recent role being a medical science liaison which involved sales and promotion of genetic tests for oncology. Brigitte has experience of KOL management and organising congresses.
Catarina executes secondary market research, analyses IVD and local pathology landscapes and builds relationships with KOLs. He facilitates projects between labs and pharma to highlight the role of Dx testing in the treatment journey.
Catarina comes from a background of Business development along with years of experience working as a sales representative and product specialist for Alere.
Clair focuses on the development of laboratory networking and the understanding of testing regulations in the UK. Clair has previous experience in academic research for Cardiovascular disease & molecular oncology, followed by several years In-Vitro toxicology in industry with focus on inflammatory mediators. She has over 10 years experience in sales, covering human genetics, oncology and prenatal testing. Clair has developed and implemented commercial strategies for products in highly regulated areas and complex markets, both in the UK and Nordic region.
Damian is responsible for overseeing operational excellence across the Company. In his position he provides the leadership, management and vision necessary to ensure that the company has the proper operational controls, administrative and reporting procedures in place to effectively grow the organisation and to ensure financial strength and operating efficiency . Damian has more than 20 years’ experience in the operation design and construction of Industrial facilities across the globe, with more than 15 years specialist Pharmaceutical experience.
Daniela execute primary and secondary market research in Germany, Austria and the German Swiss Canton, overseeing execution and facilitation of market research studies, development of laboratory relationships as well as the identification of customers’ market research needs. Daniela has over 20 years’ experience in a Pathology Lab and commercial roles.
Daniela has experience of establishing relationships with new customers as well as supporting and maintaining current customers. In addition, Daniela has also planned, organised and implemented workshops at congresses and for customers.
As Director of Engineering, David is responsible for managing the work across the Global Data Team which includes Product Design, Data Science, Data Engineering, Architecture, Infrastructure and Software Development, ensuring the right controls and procedures are in place to produce high quality software that delights our customers.
David has extensive international and cross functional experience in software, high tech and business operations having worked for companies such as Kantar Worldpanel, Mastercard and Oxford University Press.
As Scientific Director, Dawn works directly with laboratories to highlight opportunities for improved testing availability. She provides face-to-face education and workshops, engaging with advisors and key opinion leaders in relevant therapeutic areas. Dawn is an HCPC-registered biomedical scientist with over 25 years’ experience in histopathology, IHC and molecular pathology. She has worked as a lab manager/senior scientific officer/director of operations and senior biomedical scientist at the NHS and in the research, independent and EQA fields. Dawn has worked in major research and academic labs and large teaching hospitals in London. She recently provided support at UK NEQAS ICC and ISH as an assessor.
As Finance Assistant,. Deborah manages the Sales Ledger, specifically raising all sales invoices and submitting these to our clients. Deborah also monitors the invoice schedule reporting daily figures to the Finance team on the periods ahead and has responsibility for credit control, new client onboarding and providing strong admin backup to the Finance Team as a whole.
Deborah has over 10 years experience within Finance and is a member of the chartered institute of Accounts.
Derek is responsible for Innovation, leading the Product Management team to drive the development of the Nexus platform. Derek started his career in software development, moving into more customer facing and commercial roles before holding multiple positions in Product & Solution Management, Technology Strategy, Data and Analytics.
Derek has 19 years’ professional experience across several roles including engineering development, professional services, technical sales, product & solution management, analytics & strategy.
Dr. Anthony Magliocco, MD President and CEO
Dr. Magliocco MD is a Board-Certified Pathologist with over 30 years experience in tissue pathology, research, molecular diagnostics, and digital image analysis. He has founded and led multiple laboratories and has overseen the deployment of numerous new laboratory tests in his career in both Canada and the USA. Most recently he was Chairman of the Department of Anatomic Pathology at the Moffitt Cancer Center in Tampa. He was also the executive director of Esoteric Laboratory services and Scientific Director of the Moffitt Tissue Core between 2011-2019. He was the founding Director for the Moffitt Molecular Pathology Fellowship Program, and the Moffitt Digital Pathology Training Program. He has held numerous other leadership positions in Academic Societies and in the National Cooperative Clinical Trials Groups including the role of Pathology Committee Chairman for RTOG.
He has published over 200 research articles, held extensive peer reviewed grant funding, has numerous patents applied, and is a frequent invited speaker to international diagnostic technology meetings. In his research he has developed new digital image analysis methods and has led to the deployment of numerous new diagnostic tests for use in better selecting treatment plans for patients with breast, ovary, lung, bladder and many other cancers. He is a recognized key opinion leader in Advanced Laboratory Diagnostics including digital image analysis, molecular diagnostics, liquid biopsy, and precision oncology. He is also an active leader on social media and has contributed to numerous blogs, webcasts, and podcasts.
As Director, Primary Market Research, Elizabeth executes PMR projects globally, which involves client relationship, project management, communications with clients and working with the team to ensure client delight on every project. Elizabeth brings in new clients / accounts and ensures that the market research department meets its yearly target.
Elizabeth has over ten years of experience conducting all phases of primary and secondary methodologies for life science companies, with a focus and strong interest in companion diagnostics and digital health therapeutics.
As Project Financial Controller, Emanuel will have responsibility for project financial control and analytics in support of the Project Manager and Key Account Manager assigned to a portfolio of client projects, along with high-level business reporting.
Emanuel has over 5 years’ experience of Project Financial Control having worked for several companies such as Novares Portugal and Dayton Progress.
Over 4 years experience within the Private and Public sector. Hold First Class Honours Degree in Human Resource Management. A driven, innovative, self motivated and hard working person.
Dr Loupakis gained his M.D. Degree (M.D.) at the University of Pisa, Italy, in 2003, followed by the Master of Science in Clinical Trials (M.S.) in 2005, the Specialty in Oncology at the Department of Oncology of the same University in 2007 and the Research Doctorate in Health Biotechnologies (Ph.D.) in 2011. In January 2012 he was Research Fellow at the University of Southern California Keck School of Medicine, Los Angeles, CA – United States.
From 2009 to June 2016 he has worked as Medical Oncologist at the University Hospital Azienda Ospedaliero-Universitaria Pisana (AOUP), Pisa, Italy where he has been Coordinator of the Colorectal Cancer Multidisciplinary Team and Coordinator of the Trials Office of the Unit of Oncology.
In June 2016 he moved to Istituto Oncologico Veneto, IRCCS in Padua as Senior Physician where is Coordinator of the Translational Research program for GI malignancies.
Dr. Loupakis’ research field has always focused mainly on colorectal cancer, with particular attention to the transfer of the developments achieved in the field of translational research.
Frank has responsibility for establishing and developing client relationships for consulting projects, overseeing all aspects of project development, design, management and delivery.
Frank has more than 20 years’ experience with Diagnostic Companies dealing in client relations, product development/Launch, clinical/research studies and Data & Statistical analysis, within the space of Oncology.
Gladys is responsible for Developing, Facilitating and Maintaining laboratory relations throughout Canada. Communicating with key healthcare professionals on a daily basis along with actively participating in global secondary market research and biomaker landscaping . Gladys has over 10 years experience in biomarker research.
Glen is responsible for engaging with the Knowledge and Insights teams to understand how our customers consume our services and will be at the forefront of how that is refactored to an engaging, interactive SaaS experience for our customers which encompass data visualization and exploration. Glen has worked as a designer for over 20 years for a number of companies such as DisplayNote, Walker Communications, Cv3 and as a Freelance Designer and Consultant.
As a Domain Expert Helen will play a role in supporting client needs in the development of client deliverables. She will work closely with colleagues in the global matrix environment and will participate in multiple projects simultaneously under challenging timelines. The primary purpose of this position is to use expertise in market access, commercialization, personalized medicine, companion diagnostics and healthcare, together with leadership and project management skills to ensure timely execution of high-quality client projects.
Helen has many years’ experience in genomics and precision medicine and its application in oncology having worked for IBM, Sweden, OncoDNA, Belgium and CollabRx, California.
As KMS Administrator within the Project Management Office, Irene will support full implementation of the Knowledge Management System (KMS) across Diaceutics through execution of the data transfer plan whilst incorporating the project and quality management aspects required to ensure the KMS is implemented, maintained and used in compliance with cost, quality and time success factors. Irene has extensive experience of project management and implementation of electronic information/process management systems.
Isabel will be engaged in a variety of projects and will be assisting with data related client engagements during the initial scoping, proposal development through design, fulfilment execution and client presentation of projects. Izzy has an Integrated Masters in Mathematics and previously worked for PWC as an Investigative Analyst.
As Key Account Director, Jeff manages the commercial requirements of each client are delivered and exceeded. He establishes and maintains client relationships, ensuring customer delight. Jeff has extensive experience in both the pharmaceutical and diagnostic industries, building partnerships through effective identification of opportunities and implementation of Solutions.
Jeff supports the team by developing relationships with laboratories in the USA. His primary role is to leverage lab resources to enable optimized diagnostic launch planning with pharma companies. Jeff has academic and professional qualifications in business development, pathology and genetics and has had commercial leadership roles with high-complexity diagnostic testing laboratories. He has focused on healthcare partnership opportunities and building strong relationships with pathologists, physicians, administrators and C-suite executives.
As part of the quality team, Jessica ensures the high quality of deliverables by checking the consistency of presentation and clarity of the message before any decks or presentation materials are released to the client. Jessica has over 3 years experience working within genetic laboratory's.
As a Researcher in the Secondary Market Research Team, Jirawas will search and review complex and different data sources to summarize and uncover trends or gaps to project leadership according to timelines assigned. Jirawas has a strong background as an R&D scientist in cancer diagnostic device development and has extensive experience in translational/clinical cancer research, medical writing and clinical document preparation.
Joanne provides administrative support to Peter Krein, Jordan Clark and the wider Operations Team. She has over 8 years’ experience as an Executive Assistant working with CEOs/Directors in both the private and public sector. Joanne was recently EA to the CE of Northern Ireland’s largest private sector employer and has also worked in local government. She has academic qualifications in media studies and an LCCI Executive Secretary Diploma.
As a Domain Expert, John plays a key role in maintaining client relationships, and leading the design, development, management and delivery of client projects. This involves synergizing multiple inputs and research data streams to guide pharmaceutical clients in personalized medicine and diagnostic strategy.
John is a seasoned executive with over 10 years’ experience in both the life sciences and diagnostic industries combining a strong scientific background with strategic and tactical marketing experience.
Jone focuses on the development of laboratory networking and the understanding of testing regulations in Spain. She has academic qualifications in biotechnologies and molecular medicine and a background in cancer biomarker research. She is particularly interested in molecular oncology and specialized in gastric cancer.
Ms. Goonewardene is currently Vice Chancellor for Innovation & Strategic Investment at the University of Texas System (UTS), AMA Board, MBI Board and US Commerce Advisor. In addition, Julie has a track record as an experienced entrepreneur, having co-founded and served as President and CEO of Cantilever Technologies, a venture-backed software company that was successfully acquired. Cantilever’s customers were Fortune 500 companies. Prior to Cantilever, she was President of the Strategic Systems Group (SSG), a boutique information technology consulting firm, and co-founder of Technology Solutions (TSC), a professional IT services firm which went public three years after its inception. In addition to her role at UTS, Ms. Goonewardene is an author, frequent speaker and consultant on entrepreneurship and innovation. Based on success in these areas, Julie was elected to the Board of Trustees for the American Medical Association (AMA), the Board of Directors of the Personalized Medicine Coalition and Matrix-Bio and is an advisor on the National Advisory Council on Innovation and Entrepreneurship (NACIE) Board to the US Commerce Secretary. As a first generation American born to Sri Lankan and Australian parents, she brings a unique global perspective to her endeavours.
Karina is responsible for developing and leading Diaceutics Innovation strategy globally. Karina has a strong experience leading the Global Scientific Relation/Key Opinion Leader Program within Dako/Agilent and been responsible for implementation of several companion diagnostic tests within anatomic pathology for more than 20 years.
As Global Compliance and Privacy Officer, Karl will develop and implement compliant data and IT security practices, advise on, and where required carry out, staff training, raising corporate awareness, data protection impact assessments and internal audits. Karl will also serve as the primary contact for supervisory authorities.
Karl has extensive experience in global data protection / compliance having worked for CeX Webuy and undertaken many contract roles with senior law firms and pharmaceutical companies in London.
As a Domain Expert, Kate plays a key role in maintaining client relationships, and leading the design, development, management and delivery of client projects. This involves synergizing multiple inputs and research data streams to guide pharmaceutical clients in personalized medicine and diagnostic strategy.
Kate is experienced in managing and executing strategic planning, tactical launch, and market research projects in personalized medicine, clinical diagnostics, and companion diagnostics.
As a Senior Diagnostic Lab Liaison Kei will identify and implement customers’ market research needs and input into Landscape and Lab mapping/tracking projects in Japan. Kei will develop the laboratory relationships and agreement on commercial contracts with the labs.
Kei has over 18 years in the pathology area of sales/marketing. Kei worked as a Country Product Manager for a range of Diagnostic Products and Instrumentation, contributing to product planning in the global setting. He is responsible for networking and having discussions with KOLs and decision makers in the Pathology and Immunohistochemistry space across Japan.
Keith Kerr is a Consultant Pathologist for NHS Grampian and Honorary Chair in Pulmonary Pathology at the University of Aberdeen in Scotland. He has a busy diagnostic clinical practice and is active in lung cancer research. He is Chair of the IASLC Pathology Panel and served on the IASLC Board of Directors from 2013 to 2017. In 2016 he received the IASLC Mary Matthews award for Pathology and Translational Research and in 2019, the Lifetime Achievement award from the British Thoracic Oncology Group. He is a member of the ESMO Lung Educational Faculty, is Pathology Chair for the ETOP Lungscape group, and was a member of the panel for the 2004, 2015 and 2020 WHO lung cancer classifications. He has worked on numerous clinical research lung cancer trials groups, guideline panels, and conference scientific committees. He is an Associate Editor for the Journal of Thoracic Oncology. He received Honorary Fellowship of the Royal College of Physicians of Edinburgh in 2006 and Honorary Fellow of the Faculty of Pathology, Royal College of Physicians of Ireland in 2016.
Dr. Bloom has more than 30 years of clinical and business experience and has been an early adopter and big proponent of information technology to revolutionize pathology and other areas of medicine. He is also a prolific and renowned researcher and lecturer in pathology, cancer, telemedicine, and informatics.
Came to Invicro and Ambry Genetics as Chief Medical Officer of Advanced Pathology and Genomic Services in 2018 from a position at Human Longevity, Inc, as Head Oncology and Immunotherapy Program. Before that he GE Healthcare in a position as Chief Medical Officer, In Vitro Diagnostics, Life Sciences. where he was since 2011. There he had oversight of Medical Affairs, Clinical Pathology Services, Pharma Pathology Services, Bioinformatics and Research and Development. He was also President and CEO of Clarient Pathology Services, the professional group contracted to provide pathology services to Clarient Diagnostic Services and SeqWright. In these roles he led the overall development and execution of the medical and scientific strategy, aligning them with the overall GE mission and business strategy. Prior to Clarient, Dr. Bloom was with US Labs where he was Senior Medical Director since 2002.
In addition to Dr. Bloom’s extensive business experience, he has held a series of impressive academic medical posts including Clinical Professor of Pathology at University of Southern California, Keck School of Medicine, and Associate Professor of Pathology at Rush Medical College. During the last 15 years he has held more than 10 appointed positions at Rush Presbyterian-St. Luke’s Medical Center, one of the leading cancer research hospitals in the United States, including Director of Laboratory Operations, Director of Immunohistochemistry, and Director of Information Services for Rush Cancer Center.
Kevin has over 10 years experience working the IVD industry holding various sales and marketing roles. With a focus on commercialization of CDx in alignment with Rx launch and life cycle across global territories, working on regulatory approvals of IVDs including PMAs. With his knowledge and experience of in vitro diagnostic launch planning and commercialization execution, Kevin provides insights and builds strategies for unique personalized medicine project needs.
Lauren assists the EM team with lab mapping and market research. Driving efficiencies through effective data sanity checks whilst producing accurate information for our pharma clients.
Lauren has over 8 years’ experience within a Diagnostic Genetics laboratory extracting DNA and RNA from various sample types across multiple platforms. Specialising in Cytogenetic and Molecular fields including Sanger sequencing, Microarrays, RT-PCR and ddPCR.
Lee is responsible for supporting management and delivery of client projects at Diaceutics. Lee is a chemistry graduate and a Project Management accredited PMP with over 20 years experience of complex project delivery across both the pharmaceutical and diagnostics business.
As China Country Lead, Liang will lead the China team. He will lead the development of laboratory relationships and expand our Key Opinion Leader database for China. Liang will enhance Diaceutics image and knowledge platforms as well as growing the Diaceutics brand and business in China.
Liang has a Bachelor of Science, Molecular Biology and a Master of Business Administration and has 20+ years’ experience in customer support within the sequencing industry with 13 years focusing on NGS within Illumina and Roche Diagnostics.
Lisa’s role within the Finance Department is to provide timely and accurate management accounts and departmental reports as well as the provision of external reports in the form of statutory accounts and filings and regular reports to funders.
Lisa is a member of the Institute of Chartered Accountants in Ireland. She has many years experience in this field having worked for Grant Thornton, Ernst & Young, UTV Media PLC and more recently C&C Group PLC.
As a domain expert Lynn uses her expertise in personalized medicine, companion diagnostics, healthcare and laboratory practice to ensure timely execution of high-quality client projects.
Lynn brings over 10 years’ experience in the diagnostic industry, specializing in the field of Oncology.
Madeline is in charge of the day-to-day running of the company’s finance department and her duties include payroll, sales and purchase ledger, credit control and statutory returns. She has academic and professional qualifications in business and finance and linguistic science and has 20 years’ experience in a finance capacity with private sector businesses.
Marcos is responsible for providing understanding of the particularities of laboratories, regulation and reimbursement in Latin America. He has academic and professional qualifications in oncogenetics, molecular biology and business, and has expertise in molecular oncology tests, particularly qPCR and gene expression profiling. He has headed a molecular biology team and worked for a major clinical laboratory in Brazil.
Marianna monitors and describes the testing and reimbursement landscape in Europe, with a special focus on Italy. She has academic qualifications in biotechnologies and molecular medicine and a background in cancer research. She is particularly interested in molecular oncology and has expertise in HER2 positive breast cancer and GIST tumour.
Marianne leads the market research team, providing clear and actionable insights based on robust data related to the development and commercialization of companion diagnostics paired with targeted therapies. She has over 10 years’ global pharmaceutical market research experience, providing clients with insightful, actionable and high ROI research projects to answer key business questions in the US, European and Canadian markets.
Marieke works primarily on Diaceutics’ integrated solutions for measurement and tracking, producing data showing the current diagnostic test offering internationally. She has academic qualifications in Biomedical and Health Sciences and science-based business.
Dr. Eckstein studied medicine at the Friedrich-Alexander University’s Medical School in Erlangen, graduated in 2015 and received his doctoral degree in 2016. Since 2016 he is resident in surgical pathology at the Institute of Pathology of FAU Medical School (Director: Prof. Arndt Hartmann) where he trains in general pathology with focus on uropathology. He is member of the Germany Society of Pathology and the International Academy of Pathology (German Section). His main research focus lies on characterization of immune phenotypes, immune evasion mechanisms and the crucial role of immune checkpoint proteins in muscle-invasive bladder cancer. A further focus is the diagnostic assessment of PD-L1 in several cancer types, especially bladder cancer and renal cell cancer. Since the start of his residency he authored and co-authored more than 26 peer peer-reviewed original articles.
Matthew works on Diaceutics’ software products and AWS infrastructure. He has a degree in Computer Engineering and over 8 years of professional experience across a wide range of technologies. He works on the Global Data team creating solutions to allow Diaceutics and its customers analyse data.
Mick provides systems and services to support internal business activities. He manages many of the company’s business intelligence resources and evaluates and implements technologies for the software development team. Mick has academic and professional qualifications in software engineering. He has professional experience in the fields of GIS, process engineering, lean (six-sigma), environmental protection and telecommunications.
As a Diagnostic Lab Liaison Mohammed will engage with laboratories and create long lasting and mutually beneficial relationships to assist with data procurement, cultivation of KOLs, and education of all relevant stakeholders on predictive biomarkers and other topics of interest to our pharmaceutical clientele.
Mohammed has over 5 years’ experience working in Diagnostic Labs, most recent being MedLabs Diagnostics. Mohammed focus was in oncology, FISH, PCR to name a few.
As a Team Administrator, Operations, Monica provides professional and confidential administrative support to the Regional Vice-Presidents, Legal Department and Heads of Department as well as providing admin support within the Belfast Office.
Monica is a highly skilled Personal Assistant with over 11 years' experience in delivering comprehensive administrative support to senior management in various sectors throughout Northern Ireland.
As Senior Business Analyst, Nathan will be engaged in a variety of projects and will have primary responsibility for data related client engagements during the initial scoping, proposal development through design, fulfilment, execution and client presentation of projects. He will work closely with the Diaceutics global data team to ensure methodologies and analytic techniques are utilized to address client’s needs.
Nathan is AAT qualified and has many years’ experience in the field of data analysis having worked for companies such as FourEyes Insights (Healthcare Consultancy) and the Driver and Vehicles Standards Agency (DVSA).
Neil manages client projects, providing scientific and strategic insights into laboratory tests, their commercial use and integration into clinical pathways. Neil has a background in laboratory medicine and 25 years global experience in clinical diagnostic genetics laboratories, with a focus on oncology. He has been a UKNEQAS assessor and has written guidelines for analysis of laboratory tests. Neil has academic and professional qualifications in Genetics and is a Diplomate of the Royal College of Pathologists.
As Project Manager, Nigel will organize and coordinate a portfolio of client projects and internal programs and will be responsible for resource planning, timeline and deadline optimization and interdisciplinary liaison with accurate reporting of overall project progress and status for use in EXCO decision making.
Nigel has extensive project management experience having worked for several companies such as Qiagen and AstraZeneca.
Nikola supports Pharmaceutical clients’ initiatives in optimizing implementation and follow up support of specific biomarkers/companion diagnostics relevant to client’s specific needs. Along with developing strategic proposals to advance patient identification and highlight areas where potential testing leakages may occur. She is also responsible for the development of laboratory networking, the reimbursement landscape and the understanding of testing regulations in Germany.
Nikola has over 18 years experience working in medical diagnostic laboratories, both in R&D of new diagnostic tests and within a commercial testing facility.
As the business data analytics expert, Nital is responsibility for data related client engagements during the initial scoping, proposal development through design, fulfilment, execution and client presentation of projects. She works closely with internal analytics and the Diaceutics global data team to ensure methodologies and analytic techniques are utilized to address client’s needs.
Nital holds a Masters Degree in Pharmacy Administration as well as an MBA in Pharmaceutical Business and has previously held several senior positions within Symphony Health.
As a Diagnostic Lab Liaison, Olga works directly with laboratories to pinpoint channels where testing improvement may be applied. Olga is a biomedical scientist with over 12 years’ experience in epidemiology, infectious diseases, microbiology, cardiovascular science, inflammation, and biostatistics. She has worked as a test developer and researcher in largest research and academic institutions in Sweden and Russia. She is focusing on building long-term relationships with physicians, pathologists, laboratories in the Nordics countries.
As Chief Executive Officer of Diaceutics, Peter has driven the organization from its inception in 2005 to become a leader in innovative solutions that enable pharma to leverage diagnostic testing globally. He has overseen the expansion and development of Diaceutics to support pharma therapy and diagnostic commercialization via a worldwide team.
Peter recognized early on that precision medicine would be an increasingly large part of the drug development paradigm, representing a shift in how the pharmaceutical industry operates. Today, he is a thought leader in precision medicine commercialization and Diaceutics provides the top 20 precision medicine pharma companies with the data, analytics and global lab implementation services required to align biomarker and diagnostic demand with therapy, patient and revenue targets in key markets.
Peter’s role with Diaceutics complements over thirty years’ experience in international healthcare which began at GSK and Diagnology. He has operated and led companies and teams in the US, Europe, Asia and BRIC countries, inspiring product innovation and global launches while repeatedly delivering high corporate value growth for shareholders.
Peter has spent two extended periods in applied industrial research, including a year at MIT’s Pharmaceutical Program at the Sloan School of Management in Boston. He has also published widely and is a respected speaker at precision medicine events around the world.
Peter has responsibility for establishing and developing client relationships for consulting projects. In this role, he partners with the client and oversees all aspects of project development, design, management and delivery.
Peter has 20 years of experience in clinical diagnostics that spans across oncology, genetics and ID. Prior to joining Diaceutics, he served roles in R&D, business development and medical affairs that include IVD assay development, biomarker and molecular diagnostic technologies assessment, companion diagnostics partnership alliance management, and medical & technical education communication at Nanosphere, Abbott and Ventana.
As Chief Financial Officer of Diaceutics, Philip has responsibility for all administrative, financial and risk management operations. He works closely with the management team and Board of Directors to develop and implement strategies across the organization. In addition, Philip is responsible for maintaining compliance with US, UK and Republic of Ireland financial reporting, taxation and corporate governance standards.
Philip has over ten years’ financial and management experience as the Finance Director of a company in a global export market, as well as significant experience in product development, planning and product launch. He is an acting board member of a UK charity and has significant experience at board level in the charitable and not-for-profit sector. He is a member of the Institute of Chartered Accountants in Ireland, an associate member of the Institute of Taxation and a member of the Institute of Directors.
Piarella oversees the planning, development and execution of marketing strategy and implementation for our patient advocacy efforts. Here role empowers patients with regards to their diagnostic needs and to modify the diagnostic ecosystem with patients, and for patients. Piarella is a Patient Advocate with extensive experience in non-profit organisations at an international level.
Pilar focuses on the development of laboratory networking and the understanding of testing regulations in Spain. She has academic and professional qualifications in biochemistry, molecular biology, medical chemistry and biotechnology. Pilar has many years’ experience in oncological research, particularly in breast, colon and pancreatic tumours.
Prashanth is responsible for leading the development of Lab relations in Japan, South Korea, Thailand, ANZ and India by expanding our KOL database and facilitating the flow of Laboratory test information into the Diaceutics data ingestion engine. Prashanth has over 16 years’ experience of building innovative business in Biotechnology, Diagnostics, CRO, Medical Devices & Pharmaceutical industries.
Raymond is a PhD Graduate from Queen’s University Belfast (QUB) on a two-year placement as part of QUB’s Knowledge Transfer Project. He is responsible for performing research on healthcare economics and precision medicine, determining how better testing better treatment can lead to more efficient use of limited healthcare resources.
As part of the quality team, Rebecca ensures the high quality of deliverables by checking the consistency of presentation and clarity of the message before any decks or presentation materials are released to the client. Rebecca has 10 years’ experience working in a UK NHS genetic laboratory.
As Regional Vice President of Operations, US, Rick will be responsible for overseeing regional operations in the US including the execution and control of integrated, fully leveraged set of project activities and processes that deliver our services to assist Pharmaceutical companies in the development and delivery of diagnostic commercialization strategies that meet or exceed customer expectations.
Rick is an executive with over 20 years of success achieving revenue, profit and business growth objectives within complex environments, having worked for Gulfstream Healthcare and Physicians Choice.
As a Diagnostic Lab Liaison Romain will execute primary and secondary market research in France, overseeing the execution and facilitation of market research studies along with the development of laboratory relationships and the identification and implementation of customers’ market research.
Romain is an experienced account manager with more than 15 years of professional experience in sales of medical devices. Romain spent 9 years with Roche Diagnostics focusing on commercialization of laboratory reagents for medical diagnosis in the field of pathology.
Ronan assists the Project Management Team in the delivery of client projects at Diaceutics.
Ronan has recently graduated with a bachelor of Science in Physics.
As Key Account Director, Roy establishes and maintains client relationships, ensuring client satisfaction and be able to identify new opportunities and build an extensive business network within his appointed Key Clients. Roy is committed to helping clients solve problems, realise their business goals with Diaceutics solutions. Roy has over 15 years of experience in healthcare and life sciences in product marketing and sales management in APAC driving marketing strategies.
Sabit provides operational support for Pharma clients as they optimize implementation and follow-up support for biomarkers and companion diagnostics. He also highlights and improves lab testing pathways to prevent patient testing errors. Sabit has a background in molecular biology with ten years experience in neuro- and hemato-oncology labs. He has worked as Senior Scientist in research laboratories and clinical diagnostics.
As Corporate Finance, Legal and Regulatory Officer, Sally will play a key part, working in a team, creating, understanding, developing and validating investor related information with the focus on the messaging of the company and the regulatory obligations that exist as a listed company.
Sally holds a BA (Hons) in Law and is a member of the Law Society. She has worked as General Counsel and Company Secretary for a number of listed companies such as Warpaint London PLC, Grantsearch Partnership and Osmetech PLC.
Within her role Sandrine is required to execute primary and secondary market research in France, overseeing the execution and facilitation of market research studies along with the development of laboratory relationships and the identification and implementation of customers’ market research needs.
As Head of Strategic Alliances, Sarah is responsible for developing the overall alliance and partnership strategy for the Group, supporting the future growth of Diaceutics’ global business. Working closely with the senior leadership team to identify, develop and maintain broad and deep external partner relations with company partners in all solution areas. This includes negotiating commercial terms and business deal points to contract completion.
With a proven track record of driving strategic vision, operational delivery and growth, Sarah previously headed up and built Diaceutics’ Human Resources Department through the development of strategic and commercially-oriented HR interventions, cultivating high-performance teams across 23 countries.
Sarah has an academic background in Law and Human Resource Management and is a member of the Chartered Institute of Personnel Development and the Institute of Directors.
As Director of Marketing, Sarah is responsible for coordinating daily operations of the marketing department, managing our presence at global conferences and delivering events in collaboration with clients and laboratory partners. Sarah has postgraduate qualifications and an academic background in marketing, communications and public relations. With eight years professional experience in marketing and event management delivering corporate and non-profit sector events on a global scale, she brings a high level of experience to the growing Marketing department.
Sarah Short works within the HR, Finance and Administration teams. Sarah maintains and enhances the organization's human resources by planning, implementing and evaluating employee relations, policies, programs, and practices. She has academic and professional qualifications in HR and Business Management.
As Product Designer, SarahJayne will be involved in the creation and evolution of data tools, networking tools, and digital services. She will be working with others to build insights, ideas and designs to present to the team for feedback and will progress design from a business and/or user problem through to a finished prototype.
SarahJayne has over 5 years’ experience in Product and UI/UX Design having worked for Pixel Union and Citi.
Scott’s role involves organizing and coordinating a portfolio of client projects and internal programs to guide the organization toward project and program efficiencies. He provides guidance to core teams in ways that ensure efficient and high-quality projects are delivered while promoting the company’s goal to delight our clients. He holds a BMedSc (Hons) in Medical Science and is an experienced project manager with a background in medical sciences, healthcare and clinical studies in both the NHS and Vitalograph.
Scott has recently (April 2019) taken up the role of Head of Data Science within the Global Data Team at Diaceutics. Scott has 8 years experience in the data field, with a masters in data science and previous to this role, held a senior position in the advanced analytics group at Seagate Technology. He has delivered on multi-million dollar ROI projects in the field of predictive machine learning and anomaly detection and is currently leading the machine learning forefront from the Diaceutics Belfast office.
Selin focuses on the development of laboratory networking, the reimbursement landscape and the understanding of testing regulations in Turkey. She has academic qualifications in medical genetics.
Selin has previous experience working in a medical genetic laboratory and as a scientific sales and application specialist.
Sery is responsible for the development of laboratory relationships and agreement on commercial contracts with the labs to enhance the supply of Lab data and increase the Diaceutics Global Lab Network as well as the identification of customers’ market research needs.
Sery has over 6 years’ experience within the Research and Commercial field. She has supported customers at planning and implementation phase as well as managing seminars and supporting customers such as pathologists.
As a Director within the Business & Corporate Development Team, Shannon will lead/support pre- and post-sales activity to sustain and enhance client engagements with a focus on high quality delivery for all Diaceutics products and services and ongoing client development. Shannon has a strong technical and analytical background in biomedical and pharmaceutical clinical research combined with extensive experience in business operations, sales, business development, corporate development, strategic alliances, growth strategy and venture capital.
Shilpa co-leads client projects and engages with test providers to understand the real world barriers that could impede uptake of precision medicine. Shilpa has academic and professional qualifications in biochemistry and genetics and 10 years’ experience working in a diagnostic genetics service. Her expertise is in molecular genetic laboratory techniques, particularly validation and implementation of services.
As Executive VP of Sales and Marketing Steve is responsible for developing and establishing the team of key account managers to meet the needs of the business, including establishing and maintaining client relationships, ensuring client satisfaction and be able to identify new opportunities. Steve oversees the planning, development and execution of Diaceutics' marketing strategy and tactics. He drives efforts for Diaceutics to be recognized as a thought leader in the precision medicine industry and diagnostic health. Through PR, events management and digital marketing, the team leads communication efforts to promote provocative perspectives in this dynamic environment. Steve has a background in Pharma marketing to support brand launches and indications across a variety of therapeutic areas.
Susanne is responsible for leading the Knowledge And Insights Team of experts in Diaceutics. As the Pharmaceutical business model continues to change towards precision medicine there is a need to think differently and in an integrated way about the pharmaceutical and diagnostic business models from the top down in organizations. As Chief Precision Officer it is Susanne’s role to drive this agenda and help Diaceutics clients understand the critical relationship and dependency between testing and treatment and ultimately think precision medicine into corporate strategies and tactical plans.
Susanne has broad commercial experience with molecular pathology, where she has led several global launches of Companion Diagnostic products.
Tim executes primary and secondary market research in the Nordic Countries, overseeing execution and facilitation of market research studies, development of laboratory relationships as well as the identification of customers’ market research needs.
Tim has experience working in the life science industry, next generation sequencing, customer relations and technical and scientific support. Predominantly focusing on NGS products, qPCR, RNA and DNA Isolation Instrumentation mainly within the field of Oncology.
Ursula’s role covers a range of functions including Onboarding, training and development, employee relations, policies and procedures, systems updates, recruitment and probationary reviews. Ursula has over 10 years’ experience, advising and managing within the HR function, specialising in Employee Relations, Training and Learning & Development
Victoria focuses on the development of Laboratory networking and the understanding of testing regulations in the US. Victoria has over 10 years’ experience working within laboratories as well experience in technical sales and field application in the FISH/Pathology/Oncology/FFPE arena.
"I am interested in all aspects of cancer. I have been a bench tech, lead technologist, and supervisor and manager of the Cytogenetics and Molecular Cytogenetics laboratories.
My passion is identifying deficiencies and implementing process improvements for optimized productivity and customer satisfaction and retention.
I have had the great pleasure of working on many peer reviewed publications with pathologists, post doctoral fellows, vendors, and laboratory directors.
My next career goal is to obtain ceritification in Molecular Biology and sit for the certification exam MB(ASCP).
My outdoor passion is the beach and the ocean , even though living in a landlocked state does not allow me to frequent it. My favorite place to frequent is Florida.
I enjoy the ocean and the beach."
Wendy designs and codes applications that run on the web to access new Diaceutics services, such as the lab database tool. Wendy has a PhD in Cancer Drug Resistance. She has worked for Queens University Belfast for 16 years as a bioinformatician in personalised Medicine within Colo rectal Cancer.
As a Diagnostic Lab Liaison Yatish will execute primary and secondary market research mainly in UK and Ireland, overseeing execution and facilitation of market research studies, development of laboratory relationships as well as the identification of customers’ market research needs.
Yatish is a highly skilled laboratory technician specialising in Biomedical Science. Yatish most recent role is Research laboratory Manager managing a histology laboratory.
As Senior Commercial Lawyer, Yvonne will be involved in conducting risk assessments during contracts negotiation and drafting and reviewing both general and complex commercial contracts.
Yvonne holds both a Bachelor and Master Degree in Law and is a certified European Privacy Practitioner. Yvonne has worked inhouse as a Commercial Lawyer at the Office of Fair Trading and OFGEM as well as Ticketmaster UK Ltd and more recently she was the CEO and founder of an online legal support platform for SMEs.
Zarina heads the in-house legal department of Diaceutics. As General Counsel, she oversees Diaceutics’ legal and compliance functions, and provides legal advice and support to EXCO and the management team. Zarina has over 12 years of multi-jurisdictional legal experience in various industries in Asia, Europe and the US, including financial services, energy and media.